2021
Preference for and Efficacy of a PrEP Decision Aid for Women with Substance Use Disorders
Meyer J, Price C, Tracey D, Sharpless L, Song Y, Madden L, Elwyn G, Altice F. Preference for and Efficacy of a PrEP Decision Aid for Women with Substance Use Disorders. Patient Preference And Adherence 2021, 15: 1913-1927. PMID: 34511887, PMCID: PMC8420782, DOI: 10.2147/ppa.s315543.Peer-Reviewed Original ResearchSubstance use disordersPersonal HIV riskHIV preventionAddiction treatment servicesHIV riskUse disordersTreatment servicesPatient-centered decision aidAwareness of PrEPHIV prevention cascadeInitiation of PrEPPre-exposure prophylaxisOpioid use disorderStandard of careDecision aidAlcohol use severityHalf of participantsAddiction treatment programsDA participantsPrevention cascadePrimary outcomeIndependent correlatesHigh riskDecisional preferencesHigher alcohol use severity
2017
Predictors of Linkage to and Retention in HIV Care Following Release from Connecticut Jails and Prisons
Loeliger K, Altice F, Desai M, Ciarleglio M, Gallagher C, Meyer J. Predictors of Linkage to and Retention in HIV Care Following Release from Connecticut Jails and Prisons. Open Forum Infectious Diseases 2017, 4: s38-s38. PMCID: PMC5632019, DOI: 10.1093/ofid/ofx162.092.Peer-Reviewed Original ResearchTime of linkageHIV-1 RNA testsCase managementHigher medical comorbidityPredictors of linkageViral suppression statusHIV treatment outcomesCase management dataPrior observational studiesTransitional case managementHIV careMedical comorbiditiesViral suppressionDetectable viremiaRetrospective cohortHIV outcomesRNA testIndependent correlatesPsychiatric comorbidityIncarceration periodsTreatment outcomesObservational studySuppression statusTargeted interventionsComorbidities